Formulation and Process Development Strategies for Manufacturing Biopharmaceuticals 2010
DOI: 10.1002/9780470595886.ch37
|View full text |Cite
|
Sign up to set email alerts
|

Impact of Manufacturing Processes on Drug Product Stability and Quality

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 42 publications
0
1
0
Order By: Relevance
“…More recently, there has been a slow shift to continuous manufacturing, where the pharmaceuticals are produced simultaneously on a single process line, increasing both cost efficiency and product quality [9]. Among the challenges in designing these new processors for each manufacturing stage is how to mitigate adverse effects from hydrodynamic and interfacial stresses [10][11][12][13]. For example, in bioreactors where microbial factories such as E. coli are used to over-express therapeutic proteins, such as insulin via recombinant technologies, one must limit the range of shear stress imposed on the micro-organisms.…”
Section: Introductionmentioning
confidence: 99%
“…More recently, there has been a slow shift to continuous manufacturing, where the pharmaceuticals are produced simultaneously on a single process line, increasing both cost efficiency and product quality [9]. Among the challenges in designing these new processors for each manufacturing stage is how to mitigate adverse effects from hydrodynamic and interfacial stresses [10][11][12][13]. For example, in bioreactors where microbial factories such as E. coli are used to over-express therapeutic proteins, such as insulin via recombinant technologies, one must limit the range of shear stress imposed on the micro-organisms.…”
Section: Introductionmentioning
confidence: 99%